Statins induce suppressor of cytokine signaling-3 in macrophages (Q44673403)

5 December 2017

Statins induce suppressor of cytokine signaling-3 in macrophages (English)

1 reference

5 December 2017

Kuo-Chin Huang

1

0 references

author name string

Ching-Wen Chen

series ordinal

2

1 reference

5 December 2017

Jui-Ching Chen

series ordinal

3

1 reference

5 December 2017

Wan-Wan Lin

series ordinal

4

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

5 December 2017

1 reference

5 December 2017

555

1 reference

5 December 2017

2

1 reference

5 December 2017

385-389

1 reference

Jaks and STATs: biological implications

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

A family of cytokine-inducible inhibitors of signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Negative regulation of cytokine signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

The suppressors of cytokine signalling (SOCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

SOCS proteins: negative regulators of cytokine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Regulation of the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

SOCS3 negatively regulates IL-6 signaling in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

SOCS: suppressors of cytokine signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Simvastatin and lovastatin, but not pravastatin, interact with MDR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Pyrimidinoceptor-mediated potentiation of inducible nitric-oxide synthase induction in J774 macrophages. Role of intracellular calcium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

SOCS1/JAB is a negative regulator of LPS-induced macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

SOCS-1 participates in negative regulation of LPS responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Statins as a newly recognized type of immunomodulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathw

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Tumor necrosis factor alpha attenuates interferon alpha signaling in the liver: involvement of SOCS3 and SHP2 and implication in resistance to interferon therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

Posttranslational modification of proteins by isoprenoids in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901297-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-5793(03)01297-3

1 reference

5 December 2017

1 reference